Obstetrics & Gynecology Science

Gynecologic Oncology
Clinical relevance of sentinel lymph node biopsy in early ovarian cancer: Ki Eun Seon, Sang Wun Kim, Young Tae Kim; Obstet Gynecol Sci. 2023;66(6):498-508. Published online October 11, 2023; DOI: https://doi.org/10.5468/ogs.23114; Full text PubReader ePub PDF

Evaluation of follow-up observation using human epididymis protein 4, a tumor marker, in patients with ovarian cancer: Masaya Uno, Rie Matsuo, Naoki Maezawa, Tomoyasu Kato; Obstet Gynecol Sci. 2023;66(4):290-299. Published online June 28, 2023; DOI: https://doi.org/10.5468/ogs.23024; Full text PubReader ePub PDF Supplementary Material

Clinical outcomes of immunohistochemistry of the p53 Staining pattern in high-grade serous ovarian carcinoma: Panarat Orachum, Amornrat Temtanakitpaisan, Pilaiwan Kleebkaow, Bandit Chumworathayi, Sanguanchoke Luanratanakorn, Apiwat Aue-angkul, Yuwadee Itarat; Obstet Gynecol Sci. 2022;65(5):459-467. Published online July 29, 2022; DOI: https://doi.org/10.5468/ogs.22102
Web of Science 1 Crossref 1; Full text PubReader ePub PDF

Multiple biomarkers are more accurate than a combination of carbohydrate antigen 125 and human epididymis protein 4 for ovarian cancer screening: Kyung Nam Kang, Eun Young Koh, Ji Young Jang, Chul Woo Kim; Obstet Gynecol Sci. 2022;65(4):346-354. Published online April 21, 2022; DOI: https://doi.org/10.5468/ogs.22017
Web of Science 6 Crossref 7; Full text PubReader ePub PDF

Incidence and predictive factors for recurrent clear cell ovarian carcinoma: results from a single center in Thailand: Wikanda Hemman, Athithan Rattanaburi; Obstet Gynecol Sci. 2022;65(2):188-196. Published online February 23, 2022; DOI: https://doi.org/10.5468/ogs.21313
Web of Science 2 Crossref 2; Full text PubReader ePub PDF Supplementary Material

Maternal-Fetal Medicine
Ultrasonographic ovarian mass scoring system for predicting malignancy in pregnant women with ovarian mass: Se Jin Lee, Hye Rim Oh, Sunghun Na, Han Sung Hwang, Seung Mi Lee; Obstet Gynecol Sci. 2022;65(1):1-13. Published online December 14, 2021; DOI: https://doi.org/10.5468/ogs.21212
Web of Science 8 Crossref 7; Full text PubReader ePub PDF

Gynecologic Oncology
Prognostic significance of tumor laterality in advanced ovarian cancer: Yuki Yamada, Seiji Mabuchi, Naoki Kawahara, Ryuji Kawaguchi; Obstet Gynecol Sci. 2021;64(6):524-531. Published online September 14, 2021; DOI: https://doi.org/10.5468/ogs.21176
Web of Science 4 Crossref 5; Full text PubReader ePub PDF Supplementary Material

Serum lactate dehydrogenase is a possible predictor of platinum resistance in ovarian cancer: Asami Ikeda, Ken Yamaguchi, Hajime Yamakage, Kaoru Abiko, Noriko Satoh-Asahara, Kenji Takakura, Ikuo Konishi; Obstet Gynecol Sci. 2020;63(6):709-718. Published online September 17, 2020; DOI: https://doi.org/10.5468/ogs.20117
Web of Science 7 Crossref 8; Full text PubReader ePub PDF Supplementary Material

Prevalence of tumor BRCA1 and BRCA2 dysfunction in unselected patients with ovarian cancer: Roshni D. Kalachand, Ciaran O’Riain, Sinead Toomey, Aoife Carr, Kirsten M. Timms, Sharon O’Toole, Stephen Madden, Mark Bates, John J. O’Leary, Noreen Gleeson, Dearbhaile O’Donnell, Liam Grogan, Oscar Breathnach, Angela Farrelly, Britta Stordal, Bryan T. Hennessy; Obstet Gynecol Sci. 2020;63(5):643-654. Published online September 2, 2020; DOI: https://doi.org/10.5468/ogs.20033
Web of Science 4 Crossref 4; Full text PubReader ePub PDF

Associations between metabolic syndrome and gynecologic cancer: Da Yong Lee, Taek Sang Lee; Obstet Gynecol Sci. 2020;63(3):215-224. Published online March 31, 2020; DOI: https://doi.org/10.5468/ogs.2020.63.3.215
Web of Science 22 Crossref 18; Full text PubReader ePub PDF

Prognostic value of programmed cell death ligand-1 expression in ovarian cancer: an updated meta-analysis: Jinlan Piao, Hyun Ji Lim, Maria Lee; Obstet Gynecol Sci. 2020;63(3):346-356. Published online March 24, 2020; DOI: https://doi.org/10.5468/ogs.2020.63.3.346
Web of Science 9 Crossref 11; Full text PubReader ePub PDF

Robotic-assisted interval cytoreductive surgery in ovarian cancer: a feasibility study: Semiramis L. Carbajal-Mamani, David Schweer, Merry J. Markham, Ashwini K. Esnakula, Joseph R. Grajo, Jacqueline C. Castagno, Joel Cardenas-Goicoechea; Obstet Gynecol Sci. 2020;63(2):150-157. Published online February 10, 2020; DOI: https://doi.org/10.5468/ogs.2020.63.2.150
Web of Science 6 Crossref 8; Full text PubReader ePub PDF Supplementary Material

Factors associated with surgical morbidity of primary debulking in epithelial ovarian cancer: Emre Günakan, Yusuf Aytaç Tohma, Mehmet Tunç, Hüseyin Akıllı, Hanifi Şahin, Ali Ayhan; Obstet Gynecol Sci. 2020;63(1):64-71. Published online December 31, 2019; DOI: https://doi.org/10.5468/ogs.2020.63.1.64
Web of Science 16 Crossref 16; Full text PubReader PDF

Potential predictors for chemotherapeutic response and prognosis in epithelial ovarian, fallopian tube and primary peritoneal cancer patients treated with platinum-based chemotherapy: Dhammapoj Jeerakornpassawat, Prapaporn Suprasert; Obstet Gynecol Sci. 2020;63(1):55-63. Published online December 23, 2019; DOI: https://doi.org/10.5468/ogs.2020.63.1.55
Web of Science 12 Crossref 12; Full text PubReader PDF

Prevalence and oncologic outcomes of BRCA1/2 mutation and variant of unknown significance in epithelial ovarian carcinoma patients in Korea: Jun Hyeong Seo, Soo Young Jeong, Myeong Seon Kim, Jun Hyeok Kang, E Sun Paik, Yoo-Young Lee, Tae-Joong Kim, Jeong-Won Lee, Byoung-Gie Kim, Duk-Soo Bae, Chel Hun Choi; Obstet Gynecol Sci. 2019;62(6):411-419. Published online October 11, 2019; DOI: https://doi.org/10.5468/ogs.2019.62.6.411
Crossref 6; Full text PubReader ePub PDF Supplementary Material

Search